CVE-2026-105457: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in
Source GCVE Database
Not known to be exploited · CVSS 6.5 Medium : upgrade to 2.3.5-1132 when convenient.
Data as of 28 Oct 2026, 14:30 UTC
- Patch
- Available – fixed in 2.3.5-1132
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:NExploitation evidence
Disclosed: evidence found.
CVE published 28 Oct 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
Upgrade Liman MYS and havelsan/liman-mys to 2.3.5-1132.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| HAVELSAN Inc.Liman MYS | Affected
| Fixed in
|
Havelsanhavelsan/liman-myspkg:rpm/havelsan/liman-mysOther threats | Affected
| Fixed in
|
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
Since the affected versions are prior to 2.3.5-1132, upgrading to version 2.3.5-1132 or later is recommended if such a version includes a fix.
Description
CVE-2026-105457 is a path traversal vulnerability in HAVELSAN Inc. Liman MYS versions before 2.3.5-1132. This flaw allows an attacker with low privileges to access restricted directories by manipulating pathnames. The vulnerability has a CVSS 3.1 base score of 6.5, indicating a medium severity impact primarily affecting confidentiality without impacting integrity or availability.